Home / Health News / Diphtheria Kills 21 in Bangladesh

Diphtheria Kills 21 in Bangladesh

In efforts to reply to a deadly disease of diphtheria amongst Rohingya refugees in Bangladesh that has observed greater than 1,500 possible circumstances, together with 21 deaths, WHO has launched US$1.five million from its Contingency Fund for Emergencies to lend a hand finance scaling up of well being operations in Cox’s Bazar over the following six months.

The World Health Organization has deployed further group of workers and assets to reply to a abruptly spreading outbreak of diphtheria. “The Rohingya refugees are an extremely vulnerable population, with low routine vaccination coverage. WHO is applying a ‘no regrets’ policy when allocating resources to help prevent and protect communities from the spread of diphtheria and ensure that those who are sick receive critical care and treatment,” stated Dr Roderico Ofrin, Regional Emergency Director, WHO South-East Asia Regional Office. “The funds released will be crucial to sustaining our efforts until we receive more support from donors for this response.”

‘Twenty-one people have died from diphtheria in the Rohingya camps in Bangladesh.’

WHO has deployed further mavens, procured health center beds to deal with extra sufferers in diphtheria remedy centres, equipped 1,345 vials of lifesaving diphtheria anti-toxins and 300 000 doses of antibiotics, and is operating with well being government to improve ongoing vaccination efforts for each kids and well being employees.

In addition to this, WHO is operating with greater than 80 well being companions to enhance get right of entry to to very important life-saving number one and secondary well being products and services in Cox’s Bazar. For 2018, the well being sector will request further investment to lend a hand 1.2 million other folks residing in refugee camps and transient settlements.

Source: Medindia

About Aadam

Check Also

hepatitis c drug sofosbuvir 300x165 - India Grants Patent for Gilead's Hepatitis C Drug

India Grants Patent for Gilead's Hepatitis C Drug

US pharmaceutical massive Gilead has acquired a patent for its Hepatitis C drug from India. …

Leave a Reply

Your email address will not be published. Required fields are marked *